Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype
Open Access
- 18 March 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 5, 24
Abstract
Shiga toxin-producing Escherichia coli (STEC) are a group of diarrheagenic bacteria associated with foodborne outbreaks. Infection with these agents may result in grave sequelae that include fatality. A large number of STEC serotypes has been identified to date including E. coli O104:H4, an emerging pathogen that resulted in a notorious outbreak that predominantly affected Europe in 2011 leading to about 4000 infections and 50 deaths. STEC pathogenicity is highly reliant on the production of one or more Shiga toxins that can inhibit protein synthesis in host cells resulting in a cytotoxicity that may affect various organ systems. Antimicrobials are usually refrained from in the treatment of STEC infections since they are believed to induce bacterial cell lysis and the release of stored toxins. Some antimicrobials have also been reported to enhance toxin synthesis and production from these organisms. Various groups have attempted the use of alternative treatment approaches including the administration of toxin-directed antibodies, toxin-adsorbing polymers, probiotic agents and natural remedies. The utility of antibiotics in treating STEC infections has also been reconsidered in recent years with certain modalities showing promise.Keywords
This publication has 122 references indexed in Scilit:
- The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreakEMBO Molecular Medicine, 2012
- Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptidePediatric Nephrology, 2011
- Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC)Archives of Microbiology, 2011
- In Vivo and Ex Vivo Evaluations of Bacteriophages e11/2 and e4/1c for Use in the Control of Escherichia coli O157:H7Applied and Environmental Microbiology, 2010
- Inhibition of Retrograde Transport Protects Mice from Lethal Ricin ChallengeCell, 2010
- Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agentsMicrobial Pathogenesis, 2009
- Bacteriophages Reduce Experimental Contamination of Hard Surfaces, Tomato, Spinach, Broccoli, and Ground Beef by Escherichia coli O157:H7Applied and Environmental Microbiology, 2008
- Isolation and Characterization of a New T-Even Bacteriophage, CEV1, and Determination of Its Potential To Reduce Escherichia coli O157:H7 Levels in SheepApplied and Environmental Microbiology, 2006
- Application of Bacteriophages To Control Intestinal Escherichia coli O157:H7 Levels in RuminantsApplied and Environmental Microbiology, 2006
- A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2Proceedings of the National Academy of Sciences, 2006